Related Experiment Video
Updated: Feb 12, 2026

3D-Neuronavigation In Vivo Through a Patient's Brain During a Spontaneous Migraine Headache
Published on: June 2, 2014
Endocannabinoid System and Migraine Pain: An Update
Rosaria Greco1, Chiara Demartini1, Anna M Zanaboni1,2
1Laboratory of Neurophysiology of Integrative Autonomic Systems, Headache Science Centre, IRCCS Mondino Foundation, Pavia, Italy.
Migraine attacks involve the trigeminovascular system and vasoactive substances. The endocannabinoid system, particularly anandamide, is implicated, with reduced levels in chronic migraine patients suggesting a therapeutic target.
Area of Science:
- Neuroscience
- Pharmacology
- Pain Research
Background:
- Migraine pathophysiology involves trigeminovascular system activation and vasoactive mediator release.
- The endocannabinoid system (ES) is increasingly recognized for its role in pain modulation.
- Dysregulation of the ES is linked to migraine headache.
Purpose of the Study:
- To explore the connection between the endocannabinoid system and migraine.
- To investigate the role of anandamide (AEA) levels in chronic migraine (CM).
- To evaluate the therapeutic potential of targeting FAAH for migraine treatment.
Main Methods:
- Analysis of anandamide (AEA) levels in cerebrospinal fluid and plasma of chronic migraine patients.
- Review of experimental and clinical data on the endocannabinoid system and migraine.
- Exploration of the mechanism of action of fatty acid amide hydrolase (FAAH) inhibitors.
Main Results:
- Reduced anandamide (AEA) levels observed in cerebrospinal fluid and plasma of chronic migraine (CM) patients.
- This reduction in AEA is associated with enhanced pain signaling in the spinal cord.
- Fatty acid amide hydrolase (FAAH) enzyme rapidly degrades AEA, influencing its availability.
Conclusions:
- The endocannabinoid system, specifically anandamide (AEA), plays a significant role in migraine pathophysiology.
- Inhibition of AEA degradation by targeting FAAH presents a promising therapeutic strategy for migraine pain.
- Modulating AEA levels via FAAH inhibition could increase endocannabinoid availability at key migraine sites.
Related Concept Videos
Pain
Analgesia and Pain Management
Primary Motives: Sleep, Sex, and Pain Avoidance
Sleep is a fundamental physiological drive that fosters a state of restfulness crucial for several bodily functions. It facilitates body restoration, the process by which the body repairs, rejuvenates, and maintains itself during sleep, including memory...
Schemas
Biodiversity and Human Values
What is a Sensory System?

